Towards clinical translation of FLASH radiotherapy

MC Vozenin, J Bourhis, M Durante - Nature Reviews Clinical Oncology, 2022 - nature.com
The ultimate goal of radiation oncology is to eradicate tumours without toxicity to non-
malignant tissues. FLASH radiotherapy, or the delivery of ultra-high dose rates of radiation …

Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier

S Vafaei, AO Zekiy, RA Khanamir, BA Zaman… - Cancer Cell …, 2022 - Springer
Recently, immune checkpoint inhibitors (ICIs) therapy has become a promising therapeutic
strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects …

Carbon ion radiobiology

W Tinganelli, M Durante - Cancers, 2020 - mdpi.com
Simple Summary Radiotherapy with carbon ions has been used for over 20 years in Asia
and Europe and is now planned in the USA. The physics advantages of carbon ions …

Physics and biomedical challenges of cancer therapy with accelerated heavy ions

M Durante, J Debus, JS Loeffler - Nature Reviews Physics, 2021 - nature.com
Radiotherapy should have low toxicity in the entrance channel (normal tissue) and be very
effective in cell killing in the target region (tumour). In this regard, ions heavier than protons …

Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential

Y Wen, F Tang, C Tu, F Hornicek, Z Duan, L Min - Cancer letters, 2022 - Elsevier
Osteosarcoma is the most common primary malignant bone tumor and is associated with a
high risk of recurrence and distant metastasis. Effective treatment for osteosarcoma …

FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model

W Tinganelli, U Weber, A Puspitasari… - Radiotherapy and …, 2022 - Elsevier
Background and purpose The FLASH effect is a potential breakthrough in radiotherapy
because ultra-high dose-rate irradiation can substantially widen the therapeutic window …

[HTML][HTML] Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness

M Panagi, P Pilavaki, A Constantinidou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Sarcomas are uncommon malignancies of mesenchymal origin that can arise throughout the
human lifespan, at any part of the body. Surgery remains the optimal treatment modality …

Current prospects for treatment of solid tumors via photodynamic, photothermal, or ionizing radiation therapies combined with immune checkpoint inhibition (a review)

S Anand, TA Chan, T Hasan, EV Maytin - Pharmaceuticals, 2021 - mdpi.com
Photodynamic therapy (PDT) causes selective damage to tumor cells and vasculature and
also triggers an anti-tumor immune response. The latter fact has prompted the exploration of …

Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future

Z Zhang, X Tan, Z Jiang, H Wang… - Frontiers in Pharmacology, 2022 - frontiersin.org
Osteosarcoma (OS), the most common malignant tumor in the musculoskeletal system,
mainly occurs in adolescents. OS results in high mortality and disability rates due to a fatal …

Anti-PD-1/anti-PD-L1 drugs and radiation therapy: combinations and optimization strategies

J Boustani, B Lecoester, J Baude, C Latour, O Adotevi… - Cancers, 2021 - mdpi.com
Simple Summary Although immune checkpoint blockade has yielded unprecedented and
durable responses in cancer patients, the efficacy of this treatment remains limited …